首页 > 最新文献

American journal of therapeutics最新文献

英文 中文
Scropifav Antivenom Versus Supportive Care Alone in the Treatment of Pediatric Scorpion Envenomation. 斯克罗非芬抗蛇毒血清与单纯支持治疗治疗小儿蝎子中毒的比较。
IF 2.5 4区 医学 Q2 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-17 DOI: 10.1097/MJT.0000000000002046
Inbal Kestenbom, Shaked Bar-Moshe, Gidon Test, Or Kaplan, Tal Grupel, Michael Shilo, Natalya Bilenko, Michael Friger, Michal S Maimon, Dennis Scolnik, Miguel Glatstein

Background: Scorpion envenomation is a significant public health concern in specific regions and can have severe consequences in pediatric patients. The efficacy of antivenom treatment remains controversial.

Objective: To compare the clinical course and outcomes of pediatric scorpion envenomation in patients receiving SCORPIFAV antivenom versus supportive care alone.

Methods: We conducted a retrospective study of children aged 0-18 years presenting with grade ≥2 scorpion envenomation to the pediatric emergency department at Soroka University Medical Center, Israel, between 2014 and 2020. Clinical outcomes were compared between patients who received SCORPIFAV and those treated with supportive care alone.

Results: A total of 194 children were included (median age: 3 years, interquartile range: 2-8 years); 125 received SCORPIFAV and 69 received supportive care only. Patients treated with SCORPIFAV required less sedation (10.3% vs. 23.4%, P = 0.02), less analgesia (53.3% vs. 81.3%, P < 0.001), and fewer antihypertensive medications (0% vs. 17.2%, P < 0.001). SCORPIFAV administration was associated with higher odds of requiring minimal additional treatment (OR = 2.568, 95% CI, 1.168-5.646, P = 0.019). No significant differences were found in pediatric intensive care unit admission rates or length of stay.

Conclusions: In pediatric patients with grade ≥2 scorpion envenomation, SCORPIFAV use was associated with reduced need for sedatives, analgesics, and antihypertensive medications. These findings suggest that early administration of SCORPIFAV in the emergency setting may help attenuate the sympathetic response and reduce overall treatment intensity.

背景:蝎子中毒在特定地区是一个重要的公共卫生问题,可对儿科患者造成严重后果。抗蛇毒血清治疗的有效性仍然存在争议。目的:比较小儿蝎子中毒患者接受SCORPIFAV抗蛇毒血清治疗与单独支持治疗的临床过程和结局。方法:我们对2014年至2020年在以色列Soroka大学医学中心儿科急诊科就诊的0-18岁≥2级蝎子中毒儿童进行了回顾性研究。比较了接受SCORPIFAV治疗的患者和单独接受支持性治疗的患者的临床结果。结果:共纳入194例儿童(中位年龄3岁,四分位数间距2 ~ 8岁);125例接受SCORPIFAV治疗,69例仅接受支持性治疗。使用SCORPIFAV治疗的患者需要更少的镇静(10.3%对23.4%,P = 0.02)、更少的镇痛(53.3%对81.3%,P < 0.001)和更少的抗高血压药物(0%对17.2%,P < 0.001)。给药SCORPIFAV与需要最小额外治疗的几率较高相关(OR = 2.568, 95% CI, 1.168-5.646, P = 0.019)。在儿童重症监护病房住院率和住院时间方面没有发现显著差异。结论:在2级以上蝎子中毒的儿童患者中,SCORPIFAV的使用与镇静药、镇痛药和抗高血压药物的需求减少有关。这些发现表明,在紧急情况下早期使用SCORPIFAV可能有助于减轻交感神经反应并降低总体治疗强度。
{"title":"Scropifav Antivenom Versus Supportive Care Alone in the Treatment of Pediatric Scorpion Envenomation.","authors":"Inbal Kestenbom, Shaked Bar-Moshe, Gidon Test, Or Kaplan, Tal Grupel, Michael Shilo, Natalya Bilenko, Michael Friger, Michal S Maimon, Dennis Scolnik, Miguel Glatstein","doi":"10.1097/MJT.0000000000002046","DOIUrl":"https://doi.org/10.1097/MJT.0000000000002046","url":null,"abstract":"<p><strong>Background: </strong>Scorpion envenomation is a significant public health concern in specific regions and can have severe consequences in pediatric patients. The efficacy of antivenom treatment remains controversial.</p><p><strong>Objective: </strong>To compare the clinical course and outcomes of pediatric scorpion envenomation in patients receiving SCORPIFAV antivenom versus supportive care alone.</p><p><strong>Methods: </strong>We conducted a retrospective study of children aged 0-18 years presenting with grade ≥2 scorpion envenomation to the pediatric emergency department at Soroka University Medical Center, Israel, between 2014 and 2020. Clinical outcomes were compared between patients who received SCORPIFAV and those treated with supportive care alone.</p><p><strong>Results: </strong>A total of 194 children were included (median age: 3 years, interquartile range: 2-8 years); 125 received SCORPIFAV and 69 received supportive care only. Patients treated with SCORPIFAV required less sedation (10.3% vs. 23.4%, P = 0.02), less analgesia (53.3% vs. 81.3%, P < 0.001), and fewer antihypertensive medications (0% vs. 17.2%, P < 0.001). SCORPIFAV administration was associated with higher odds of requiring minimal additional treatment (OR = 2.568, 95% CI, 1.168-5.646, P = 0.019). No significant differences were found in pediatric intensive care unit admission rates or length of stay.</p><p><strong>Conclusions: </strong>In pediatric patients with grade ≥2 scorpion envenomation, SCORPIFAV use was associated with reduced need for sedatives, analgesics, and antihypertensive medications. These findings suggest that early administration of SCORPIFAV in the emergency setting may help attenuate the sympathetic response and reduce overall treatment intensity.</p>","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145766617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
L-Type Calcium Channel Blockers, Extrapyramidal Symptoms, and Delirium: A Systematic Review of Case Reports. l型钙通道阻滞剂、锥体外系症状和谵妄:病例报告的系统回顾。
IF 2.5 4区 医学 Q2 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-17 DOI: 10.1097/MJT.0000000000002074
Dondapati Venkata Vamshi Krishna, Abhimanyu Velmurugan, Adupala Sreeman Reddy, Aniket Shyam Kurmi, Satyam Sharma, Sankha Shubhra Chakrabarti, Upinder Kaur
{"title":"L-Type Calcium Channel Blockers, Extrapyramidal Symptoms, and Delirium: A Systematic Review of Case Reports.","authors":"Dondapati Venkata Vamshi Krishna, Abhimanyu Velmurugan, Adupala Sreeman Reddy, Aniket Shyam Kurmi, Satyam Sharma, Sankha Shubhra Chakrabarti, Upinder Kaur","doi":"10.1097/MJT.0000000000002074","DOIUrl":"https://doi.org/10.1097/MJT.0000000000002074","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145766550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Head-To-Head Comparison of Diclofenac Versus Indomethacin for the Prophylaxis of Post-ERCP Pancreatitis: A Systematic Review and Meta-Analysis. 双氯芬酸与吲哚美辛预防ercp后胰腺炎的正面比较:系统评价和荟萃分析。
IF 2.5 4区 医学 Q2 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-16 DOI: 10.1097/MJT.0000000000002090
Abdallfatah Abdallfatah, Ahmed Hamdy G Ali, Samaa Daoud, Douglas G Adler
{"title":"A Head-To-Head Comparison of Diclofenac Versus Indomethacin for the Prophylaxis of Post-ERCP Pancreatitis: A Systematic Review and Meta-Analysis.","authors":"Abdallfatah Abdallfatah, Ahmed Hamdy G Ali, Samaa Daoud, Douglas G Adler","doi":"10.1097/MJT.0000000000002090","DOIUrl":"https://doi.org/10.1097/MJT.0000000000002090","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145762030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Use of Beta-Blockers After Myocardial Infarction in Patients With Left Ventricular Ejection Fraction of More Than 40%: A Meta-Analysis. 左心室射血分数超过40%的患者心肌梗死后β受体阻滞剂的使用:一项荟萃分析
IF 2.5 4区 医学 Q2 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-16 DOI: 10.1097/MJT.0000000000002096
Ahmad Al-Abdouh, Ahmad Jabri, Mohammed Mhanna, Laith Alhuneafat, Deya Alkhatib, Ibrahim Mortada, Shareef Mansour, Wissam Khalife
{"title":"The Use of Beta-Blockers After Myocardial Infarction in Patients With Left Ventricular Ejection Fraction of More Than 40%: A Meta-Analysis.","authors":"Ahmad Al-Abdouh, Ahmad Jabri, Mohammed Mhanna, Laith Alhuneafat, Deya Alkhatib, Ibrahim Mortada, Shareef Mansour, Wissam Khalife","doi":"10.1097/MJT.0000000000002096","DOIUrl":"https://doi.org/10.1097/MJT.0000000000002096","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145762110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Acute Pancreatitis Related to Therapeutic Dosing With Colchicine and Review of the Literature. 与秋水仙碱治疗相关的急性胰腺炎1例及文献复习。
IF 2.5 4区 医学 Q2 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-11 DOI: 10.1097/MJT.0000000000002087
Dhouha Sahnoun, Myriam Agrebi, Chayma Ladhari, Hajer Bouraoui, Nejla El Amri, Elyes Bouajina, Chaker Ben Salem
{"title":"A Case of Acute Pancreatitis Related to Therapeutic Dosing With Colchicine and Review of the Literature.","authors":"Dhouha Sahnoun, Myriam Agrebi, Chayma Ladhari, Hajer Bouraoui, Nejla El Amri, Elyes Bouajina, Chaker Ben Salem","doi":"10.1097/MJT.0000000000002087","DOIUrl":"https://doi.org/10.1097/MJT.0000000000002087","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145720415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Discontinuing Renin-Angiotensin-Aldosterone System Inhibitors With or Without Calcium Channel Blockers on Cardiovascular Outcomes in Noncardiac Surgery: A Meta-Analysis of Randomized Controlled Trials. 停用肾素-血管紧张素-醛固酮系统抑制剂联合或不联合钙通道阻滞剂对非心脏手术心血管结局的影响:一项随机对照试验的荟萃分析
IF 2.5 4区 医学 Q2 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-09 DOI: 10.1097/MJT.0000000000002068
Cara Mohammed, Muhammad Waqi Qamar, Basanta Pathak, Madiha Shareef, Rimsha Saeed Ahmed, Anas Shihab, Umair Khalid, Gagandeep Singh, Areehah Zafar Masood, Rai Dilawar Shahjehan, Sarah MacKenzie Picker, Raheel Ahmed, Mushood Ahmed, Muhammad Ehsan
{"title":"Impact of Discontinuing Renin-Angiotensin-Aldosterone System Inhibitors With or Without Calcium Channel Blockers on Cardiovascular Outcomes in Noncardiac Surgery: A Meta-Analysis of Randomized Controlled Trials.","authors":"Cara Mohammed, Muhammad Waqi Qamar, Basanta Pathak, Madiha Shareef, Rimsha Saeed Ahmed, Anas Shihab, Umair Khalid, Gagandeep Singh, Areehah Zafar Masood, Rai Dilawar Shahjehan, Sarah MacKenzie Picker, Raheel Ahmed, Mushood Ahmed, Muhammad Ehsan","doi":"10.1097/MJT.0000000000002068","DOIUrl":"https://doi.org/10.1097/MJT.0000000000002068","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145707009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful Treatment of Evans Syndrome With efgartigimod: A Case Report. 艾加替吉莫德成功治疗埃文斯综合征1例。
IF 2.5 4区 医学 Q2 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-08 DOI: 10.1097/MJT.0000000000002066
Yasuyuki Inoue, Shigeki Kosugi
{"title":"Successful Treatment of Evans Syndrome With efgartigimod: A Case Report.","authors":"Yasuyuki Inoue, Shigeki Kosugi","doi":"10.1097/MJT.0000000000002066","DOIUrl":"https://doi.org/10.1097/MJT.0000000000002066","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145699635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful Treatment of Relapsed Transformed Aggressive B-Cell Lymphoma After Autologous Hematopoietic Stem Cell Transplantation With Polatuzumab Vedotin Combined With Bendamustine and Rituximab Followed by Nonmyeloablative Related HLA-Identical Stem Cell Transplantation. Polatuzumab Vedotin联合苯达莫司汀和利妥昔单抗成功治疗自体造血干细胞移植后复发的转化侵袭性b细胞淋巴瘤,随后进行非清髓性相关hla -相同干细胞移植。
IF 2.5 4区 医学 Q2 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-08 DOI: 10.1097/MJT.0000000000002063
Shigeki Kosugi, Yasuyuki Inoue
{"title":"Successful Treatment of Relapsed Transformed Aggressive B-Cell Lymphoma After Autologous Hematopoietic Stem Cell Transplantation With Polatuzumab Vedotin Combined With Bendamustine and Rituximab Followed by Nonmyeloablative Related HLA-Identical Stem Cell Transplantation.","authors":"Shigeki Kosugi, Yasuyuki Inoue","doi":"10.1097/MJT.0000000000002063","DOIUrl":"https://doi.org/10.1097/MJT.0000000000002063","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145706997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of an Elderly Bullous Pemphigoid Patient With Enterostomy Was Effectively Treated With Dupilumab. 老年大疱性类天疱疮合并肠造口术1例经Dupilumab有效治疗。
IF 2.5 4区 医学 Q2 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-04 DOI: 10.1097/MJT.0000000000001771
Sheng Li, Bing-Jun Shi
{"title":"A Case of an Elderly Bullous Pemphigoid Patient With Enterostomy Was Effectively Treated With Dupilumab.","authors":"Sheng Li, Bing-Jun Shi","doi":"10.1097/MJT.0000000000001771","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001771","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145666699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tofacitinib for the Treatment of Refractory Severe Acute Urticaria: A Retrospective Case Series. 托法替尼治疗难治性严重急性荨麻疹:回顾性病例系列。
IF 2.5 4区 医学 Q2 PHARMACOLOGY & PHARMACY Pub Date : 2025-11-26 DOI: 10.1097/MJT.0000000000002076
Anqi Chen, Xianjie Yang, Xuewei Huang, Shifei Li, Huan Wang, Sisi Deng, Zhiqiang Song, Qiquan Chen
{"title":"Tofacitinib for the Treatment of Refractory Severe Acute Urticaria: A Retrospective Case Series.","authors":"Anqi Chen, Xianjie Yang, Xuewei Huang, Shifei Li, Huan Wang, Sisi Deng, Zhiqiang Song, Qiquan Chen","doi":"10.1097/MJT.0000000000002076","DOIUrl":"https://doi.org/10.1097/MJT.0000000000002076","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145647025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American journal of therapeutics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1